Fig. 4
From: Unveiling CCR9 and CCL13 as immune biomarkers and therapeutic targets in thymoma
Verification of the 3 potential biomarkers. (A) The expression patterns of the potential biomarkers in training set. (B) Receiver Operating Characteristic (ROC) curve analysis of the training set. (C) The expression patterns of the potential biomarkers in validation set. (D) ROC curve analysis of the validation set.
